The Experience of Patients and Family Caregivers in Managing Pneumoconiosis in the Family Context

NCT ID: NCT04022902

Last Updated: 2021-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

83 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-10-05

Study Completion Date

2019-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an exploratory qualitative study to understand the needs of patients with pneumoconiosis, and the care-giving experience of their family caregivers. Patients with a confirmed diagnosis of pneumoconiosis for at least 1 year and had registered with the Pneumoconiosis Compensation Fund Board in Hong Kong to receive compensation will be eligible to join this study. The respective family caregivers of these patients, who are 21 years of age or older, assuming the role as the primary caregivers of a pneumoconiosis patient who have registered with the Pneumoconiosis Compensation Fund Board will be invited to join. The nurse will carry out an individual in-depth qualitative interview at patient's home. The nurse will also conduct a home environment assessment. After obtaining the written consent, an interview guide with a list of open-ended questions will be used to elicit the illness experience and self-care needs of the pneumoconiosis patients and the caregiving experience of their family caregivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pneumoconiosis is a fibrotic pulmonary disease resulting from workplace exposure to hazardous dusts containing free silica or asbestos, which causes irreversible progressive respiratory impairment among the sufferers. These patients may experience disabling symptoms (e.g. progressive severe dyspnea, chronic and uncontrolled cough, sputum production, fatigue, activity intolerance, decreased mobility and sleep disturbance) despite optimal medical treatment. Pneumoconiosis is considered as a chronic, progressive and incurable disease which requires long-term comprehensive rehabilitation services and support. Effective disease management relies on engaging patients in long-term comprehensive rehabilitation. The overall aim of this study is to explore the illness experience and needs of patients with pneumoconiosis, and the caregiving experience of their respective family caregivers through home visits. The findings will provide important insight into the development of an effective and tailor-made support program for patients with pneumoconiosis in Hong Kong.

This is an exploratory qualitative study to understand the needs of patients with pneumoconiosis, and the care-giving experience of their family caregivers. Patients with a confirmed diagnosis of pneumoconiosis for at least 1 year and had registered with the Pneumoconiosis Compensation Fund Board in Hong Kong to receive compensation will be eligible to join this study. The respective family caregivers of these patients, who are 21 years of age or older, assuming the role as the primary caregivers of a pneumoconiosis patient who have registered with the Pneumoconiosis Compensation Fund Board will be invited to join. The nurse will carry out an individual in-depth qualitative interview at patient's home. The nurse will also conduct a home environment assessment, as the home environment plays an important role in promoting or restricting performance of everyday tasks of people with disabling chronic diseases and their caregivers. The interviews will be conducted with the patients and the caregivers separately, so they can talk openly and confidentiality is guaranteed. Prior to commencement of the data collection, the nurse will provide an information sheet to solicit participants' understanding about the nature of the study, their rights and confidentiality issues. After obtaining the written consent, an interview guide with a list of open-ended questions will be used to elicit the illness experience and self-care needs of the pneumoconiosis patients and the caregiving experience of their family caregivers. All the interviews will be audio-taped after obtaining the permission from the participants.

This study aims to explore the illness experience and needs of patients with pneumoconiosis and the care-giving experience of their caregivers. Specifically, the objectives of this study are as follow:

* To understand the self-care behaviors and illness experience of patients with pneumoconiosis
* To explore the needs of patients with pneumoconiosis when managing the disease at home and in the community
* To understand the caregiving experience of the family caregivers of patients with pneumoconiosis
* To explore the caregivers' needs when taking care of patients with pneumoconiosis
* To explore how disease management and caregiving take place in patients' home environment and to identify the environment-related facilitators and barriers for managing pneumoconiosis.

After the interview, the nurse will also conduct a home environment assessment with a standard environmental checklist to evaluate the home for safety, modification needs and ease of mobility. Such assessment would provide valuable information to inform the needs of pneumoconiosis patients and their caregivers when they participate community-based and home-based rehabilitative activities. The assessment includes the environment outside and within patients' home environment, such as any difficulties in accessing the entrance of the building (e.g. barrier-free entryway, no elevator for one or more floor), the use of equipment or adaptations in the home to aid in daily activities, such as rails and commodes. The commonly seen home environmental hazards will also be assessed, such as the exposure to second-hand smoking, the use of nonskid mats in bathroom, grab bars in the shower or tub, spacing and entryway in the bathroom and bedroom. Each of the item will be assessed to solicit a 'no problem observed' or 'problem observed'.

The audio-taped qualitative data will be transcribed verbatim by the research nurse. Content analysis will be adopted for the data analysis. In particular, the qualitative data will be analyzed to seek a better understanding of what and how the patients and the caregivers can be supported in their disease self-care and caregiving trajectory. The emerged themes from the qualitative data will be used to optimize the patient support program in the subsequent quantitative phase of the study. The home environment assessment data will be summarized by appropriate numbers and percentages.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumoconiosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

This is an exploratory qualitative study to understand the needs of patients with pneumoconiosis, and the care-giving experience of their family caregivers.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Qualitative study

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For Patients:

* a confirmed diagnosis of pneumoconiosis for at least 1 year
* had registered with the Pneumoconiosis Compensation Fund Board in Hong Kong to receive compensation

For the respective family caregivers:

* 21 years of age or older
* assuming the role as the primary caregivers of a pneumoconiosis patient who have registered with the Pneumoconiosis Compensation Fund Board

Exclusion Criteria

* Those patients or family caregivers with impaired communication ability or impaired cognitive function \[as indicated by the Abbreviated Mental Test (AMT) score ≤ 6/10\] in preventing them to participate in the research activities will be excluded.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Li Wai Chi Polly

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Polly Li, Prof

Role: PRINCIPAL_INVESTIGATOR

The Nethersole School of Nursing

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pneumoconiosis Compensation Fund Board

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

References

Explore related publications, articles, or registry entries linked to this study.

Li PWC, Yu DSF, Tam SYS. The experience of patients and family caregivers in managing pneumoconiosis in the family context: A study protocol. J Adv Nurs. 2019 Dec;75(12):3805-3811. doi: 10.1111/jan.14203. Epub 2019 Oct 2.

Reference Type DERIVED
PMID: 31576609 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PCFB2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fan Therapy in COPD Patients
NCT03137524 COMPLETED NA